Izidore Lossos, MD
Izidore Lossos, MD
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma | Extranodal Marginal Zone Lymphoma | Recruiting | Phase 2 | 2025-11-03 | NCT06569680 | |
| Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL) | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, MALT lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm, nodal marginal zone B-cell lymphoma, splenic marginal zone lymphoma | Recruiting | Phase 2 | 2025-10-28 | NCT06796998 |